18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and astrocytes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Spinal cord injury (SCI) is a catastrophic injury that can cause irreversible motor dysfunction with high disability. Exosomes participate in the transport of miRNAs and play an essential role in intercellular communication via transfer of genetic material. However, the miRNAs in exosomes which derived from neurons, and the underlying mechanisms by which they contribute to SCI remain unknown.

          Methods

          A contusive in vivo SCI model and a series of in vitro experiments were carried out to explore the therapeutic effects of exosomes. Then, a miRNA microarray analysis and rescue experiments were performed to confirm the role of neuron-derived exosomal miRNA in SCI. Western blot, luciferase activity assay, and RNA-ChIP were used to investigate the underlying mechanisms.

          Results

          The results indicated that neuron-derived exosomes promoted functional behavioral recovery by suppressing the activation of M1 microglia and A1 astrocytes in vivo and in vitro. A miRNA array showed miR-124-3p to be the most enriched in neuron-derived exosomes. MYH9 was identified as the target downstream gene of miR-124-3p. A series of experiments were used to confirm the miR-124-3p/MYH9 axis. Finally, it was found that PI3K/AKT/NF-κB signaling cascades may be involved in the modulation of microglia by exosomal miR-124-3p.

          Conclusion

          A combination of miRNAs and neuron-derived exosomes may be a promising, minimally invasive approach for the treatment of SCI.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          Extracellular vesicles round off communication in the nervous system.

          Functional neural competence and integrity require interactive exchanges among sensory and motor neurons, interneurons and glial cells. Recent studies have attributed some of the tasks needed for these exchanges to extracellular vesicles (such as exosomes and microvesicles), which are most prominently involved in shuttling reciprocal signals between myelinating glia and neurons, thus promoting neuronal survival, the immune response mediated by microglia, and synapse assembly and plasticity. Such vesicles have also been identified as important factors in the spread of neurodegenerative disorders and brain cancer. These extracellular vesicle functions add a previously unrecognized level of complexity to transcellular interactions within the nervous system.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Emerging roles of astrocytes in neural circuit development.

            Astrocytes are now emerging as key participants in many aspects of brain development, function and disease. In particular, new evidence shows that astrocytes powerfully control the formation, maturation, function and elimination of synapses through various secreted and contact-mediated signals. Astrocytes are also increasingly being implicated in the pathophysiology of many psychiatric and neurological disorders that result from synaptic defects. A better understanding of how astrocytes regulate neural circuit development and function in the healthy and diseased brain might lead to the development of therapeutic agents to treat these diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The cellular inflammatory response in human spinal cords after injury.

              Spinal cord injury (SCI) provokes an inflammatory response that generates substantial secondary damage within the cord but also may contribute to its repair. Anti-inflammatory treatment of human SCI and its timing must be based on knowledge of the types of cells participating in the inflammatory response, the time after injury when they appear and then decrease in number, and the nature of their actions. Using post-mortem spinal cords, we evaluated the time course and distribution of pathological change, infiltrating neutrophils, monocytes/macrophages and lymphocytes, and microglial activation in injured spinal cords from patients who were 'dead at the scene' or who survived for intervals up to 1 year after SCI. SCI caused zones of pathological change, including areas of inflammation and necrosis in the acute cases, and cystic cavities with longer survival (Zone 1), mantles of less severe change, including axonal swellings, inflammation and Wallerian degeneration (Zone 2) and histologically intact areas (Zone 3). Zone 1 areas increased in size with time after injury whereas the overall injury (size of the Zones 1 and 2 combined) remained relatively constant from the time (1-3 days) when damage was first visible. The distribution of inflammatory cells correlated well with the location of Zone 1, and sometimes of Zone 2. Neutrophils, visualized by their expression of human neutrophil alpha-defensins (defensin), entered the spinal cord by haemorrhage or extravasation, were most numerous 1-3 days after SCI, and were detectable for up to 10 days after SCI. Significant numbers of activated CD68-immunoreactive ramified microglia and a few monocytes/macrophages were in injured tissue within 1-3 days of SCI. Activated microglia, a few monocytes/macrophages and numerous phagocytic macrophages were present for weeks to months after SCI. A few CD8(+) lymphocytes were in the injured cords throughout the sampling intervals. Expression by the inflammatory cells of the oxidative enzymes myeloperoxidase (MPO) and nicotinamide adenine dinucleotide phosphate oxidase (gp91(phox)), and of the pro-inflammatory matrix metalloproteinase (MMP)-9, was analysed to determine their potential to cause oxidative and proteolytic damage. Oxidative activity, inferred from MPO and gp91(phox) immunoreactivity, was primarily associated with neutrophils and activated microglia. Phagocytic macrophages had weak or no expression of MPO or gp91(phox). Only neutrophils expressed MMP-9. These data indicate that potentially destructive neutrophils and activated microglia, replete with oxidative and proteolytic enzymes, appear within the first few days of SCI, suggesting that anti-inflammatory 'neuroprotective' strategies should be directed at preventing early neutrophil influx and modifying microglial activation.
                Bookmark

                Author and article information

                Contributors
                dongdongjiang@njmu.edu.cn
                gfynjmu@163.com
                gxhnjmu@163.com
                bckkknjmu@163.com
                huangcychn@njmu.edu.cn
                289567440@qq.com
                jtt2008njmu@163.com
                504096982@qq.com
                wjxnjmu@163.com
                jcynjmu@163.com
                chenjiancjnjmu@163.com
                zwe99@126.com
                fanjinnjmu@163.com
                liuweiorth@njmu.edu.cn
                caiwhsubmission@sina.com
                Journal
                J Nanobiotechnology
                J Nanobiotechnology
                Journal of Nanobiotechnology
                BioMed Central (London )
                1477-3155
                25 July 2020
                25 July 2020
                2020
                : 18
                : 105
                Affiliations
                [1 ]GRID grid.412676.0, ISNI 0000 0004 1799 0784, Department of Orthopaedics, , The First Affiliated Hospital of Nanjing Medical University, ; Nanjing, 210029 Jiangsu China
                [2 ]GRID grid.459351.f, Department of Orthopaedics, , Yancheng Third People’s Hospital, ; Yancheng, 224000 Jiangsu China
                [3 ]Department of Orthopaedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006 Jiangsu China
                [4 ]GRID grid.410745.3, ISNI 0000 0004 1765 1045, Department of Encephalopathy, , The Third Affiliated Hospital of Nanjing University of Chinese Medicine, ; Nanjing, 210001 Jiangsu China
                [5 ]GRID grid.89957.3a, ISNI 0000 0000 9255 8984, Department of Analytical & Testing Center, , Nanjing Medical University, ; Nanjing, 211666 Jiangsu China
                Article
                665
                10.1186/s12951-020-00665-8
                7382861
                32711535
                015d81cf-f4d3-46db-84c1-3d4d1a01ac9e
                © The Author(s) 2020

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 20 April 2020
                : 20 July 2020
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 81974335
                Award ID: 81902211
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100004608, Natural Science Foundation of Jiangsu Province;
                Award ID: BK20181490
                Award ID: BK20191061
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100010014, Six Talent Peaks Project in Jiangsu Province;
                Award ID: TD-SWYY-010
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100007452, Wu Jieping Medical Foundation;
                Categories
                Research
                Custom metadata
                © The Author(s) 2020

                Biotechnology
                spinal cord injury,exosomes,microglia,astrocytes,mir-124-3p/myh9 axis
                Biotechnology
                spinal cord injury, exosomes, microglia, astrocytes, mir-124-3p/myh9 axis

                Comments

                Comment on this article

                scite_
                192
                7
                143
                0
                Smart Citations
                192
                7
                143
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content89

                Cited by114

                Most referenced authors641